cbdMD, Inc. (YCBD)
ASE · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About cbdMD, Inc.
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 4.6M | 4.7M | 5.0M | 5.6M |
| Gross Profit | 2.8M | 2.8M | 3.0M | 3.3M |
| Operating Income | -905K | -686K | -286K | -801K |
| Net Income | -895K | -680K | -283K | -798K |
| Diluted EPS | $-0.21 | $nan | $-0.04 | $-0.08 |
Annual Financials
| Metric | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 35.4M | 24.2M | 19.5M | 19.2M |
| Gross Profit | 22.3M | 15.0M | 12.0M | 12.0M |
| Operating Income | -17.3M | -9.3M | -3.3M | -2.2M |
| Net Income | -70.1M | -22.9M | -3.7M | -2.0M |
| Diluted EPS | $-446.40 | $-106.56 | $-14.29 | $-1.09 |